Sector: MedicalMartek Biosciences Corporation (NASDAQ: MATK)
Headlines
- Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from Ragasa
Sep 21, 2009 03:55 PM | MATK
- Martek Announces Addition to Its Board of Directors
Sep 16, 2009 04:57 PM | GSK, MATK
- Martek to Present at Two Upcoming Investor Conferences
Sep 15, 2009 09:02 AM | MATK, UBS
- Martek Announces Settlement of Patent Dispute with Capsugel France
Sep 10, 2009 09:45 AM | MATK
- Federal Circuit Rules in Martek's Favor in Appeal of Patent Infringement Case
Sep 08, 2009 06:03 PM | MATK
- E.T. Horn Signs Unprecedented Deal with Martek to Distribute life'sDHA(TM) Within the Nutraceuticals Market
Aug 26, 2009 06:41 PM | MATK
- Thriving to Diving: 36 Winners Last Year Struggling This Year
Jul 27, 2009 01:13 AM | ACET, EZPW, MATK, MPR, SYNO
- Martek Biosciences: Time To Revisit
Jul 12, 2009 01:20 PM | MATK
- Stocks Of The Day: Green Mountain Coffee Roasters (NasdaqGS: GMCR), Martek Biosciences (NasdaqGS: MATK)
Jun 05, 2009 12:00 PM | GMCR, MATK, WMT
- Earnings Review: March 04, 2009
Mar 04, 2009 07:35 PM | ALLI, CWTR, FL, MATK, SIGM
- Martek Announces Third Quarter 2009 Financial Results
Sep 02, 2009 04:51 PM | MATK
- Martek Announces Third Quarter 2009 Financial Results ; - Record Non-Infant Formula Nutritional Sales of $10.6 Million, Increase of 41% Over Third Quarter of 2008; - Record Quarterly Gross Margin of 43.7%; - Third Quarter Total Revenues and Earnings in Line With Previously Disclosed Guidance; - Fourth Quarter 2009 Revenue Guidance of $87 Million to $92 Million; - Full Fiscal Year 2009 Earnings Guidance of $1.20 to $1.24 Per Share, Projected Pre-Tax Earnings Growth of 10% to 15% Over Fiscal 2008
Sep 02, 2009 02:51 PM | MATK
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Aug 20, 2009 04:05 PM | MATK
- Martek to Announce Third Quarter 2009 Results
Aug 19, 2009 09:00 AM | MATK
- Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
Aug 13, 2009 04:05 PM | MATK
- BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels ; Collaboration Assembles Core Capabilities Across Biofuels Value Chain to Develop Biodiesel Production Using Sugar Feedstocks
Aug 11, 2009 07:53 AM | MATK
- BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
Aug 11, 2009 07:31 AM | MATK
- Martek to Present at Upcoming Canaccord Adams Conference
Jul 28, 2009 04:06 PM | MATK
- EU Committee Approves New Food Applications for Martek's life'sDHA(TM)
Jul 17, 2009 12:20 PM | MATK
- Reminder: Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria
Jul 13, 2009 08:02 AM | MATK
- Form 4/A Pernock David M For: Sep 17 (10K)
Oct 30, 2009 08:46 PM
- Form 4 Pernock David M For: Sep 17 (10K)
Sep 17, 2009 06:48 PM
- Form 3 Pernock David M For: Sep 16 (10K)
Sep 17, 2009 06:43 PM
- Form 4 Fealey Terence For: Sep 04 (10K)
Sep 09, 2009 06:34 PM
- Form 4 MARTEK BIOSCIENCES CORP For: Jun 05 Filed by: Devine Michael G (10K)
Jun 08, 2009 06:31 PM
- Form 4 ROTBERG EUGENE H For: Mar 19 (10K)
Mar 23, 2009 05:42 PM
- Form 4 MAYER ROBERT H For: Mar 19 (10K)
Mar 23, 2009 05:41 PM
- Form 4 MACMASTER JR DOUGLAS J For: Mar 19 (10K)
Mar 23, 2009 05:41 PM
- Form 4 Nitze Peter A For: Mar 19 (10K)
Mar 23, 2009 05:40 PM
- Form 4 KELLER JEROME C For: Mar 19 (10K)
Mar 23, 2009 05:38 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MATK
|
Compare to S&P
|
| YTD |
-40.75 %
|
-48.35 %
|
| 4 Weeks |
-16.08 %
|
-16.96 %
|
| 12 Weeks |
-24.41 %
|
-26.29 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -18.18 %
|
|
EPS Growth in Last Year: -3.57 %
|
|
Sales Growth in Last Quarter: -15.77 %
|
|
Sales Growth in Last Quarter: -11.96 %
|
|
